Karen Kelly, MD

Articles by Karen Kelly, MD

Questioning When to Start Immunotherapy for Patients With Oncogenic Drivers

ByKaren Kelly, MD

May 21st 2020

Karen Kelly, MD, discusses how oncogenic drivers affect the use and placement of immunotherapy for patients with lung cancer.

Latest Updated Articles

Trending on Targeted Onc

FDA Approves Amivantamab and Hyaluronidase for Recurrent/Metastatic HNSCC

Zocilurtatug Pelitecan Shows Activity in epNEC Across DLL3 Expression Levels

Dr Mohamed on Zocilurtatug Pelitecan for Refractory Extrapulmonary NEC

LITESPARK-011 Raises Questions About RCC Treatment Sequencing

COA Backs 340B Payment Cut in 2027 Final Rules, Warns of Physician Cuts